BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1419644)

  • 1. Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.
    Ravaud A; Bui NB; Coindre JM; Lagarde P; Tramond P; Bonichon F; Stöckle E; Kantor G; Trojani M; Chauvergne J
    Br J Cancer; 1992 Nov; 66(5):961-9. PubMed ID: 1419644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
    Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
    Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A staging system for soft-tissue sarcoma and its evaluation in relation to treatment.
    Tomita Y; Kuratsu S; Naka N; Uchida A; Ono K; Ohsawa M; Aozasa K
    Int J Cancer; 1994 Jul; 58(2):168-73. PubMed ID: 8026876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis following locally recurrent soft-tissue sarcoma. A staging system based on primary and recurrent tumour characteristics.
    Choong PF; Gustafson P; Willén H; Akerman M; Baldetrop B; Fernö M; Alvegård T; Rydholm A
    Int J Cancer; 1995 Jan; 60(1):33-7. PubMed ID: 7814149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
    Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
    Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
    Coindre JM; Terrier P; Bui NB; Bonichon F; Collin F; Le Doussal V; Mandard AM; Vilain MO; Jacquemier J; Duplay H; Sastre X; Barlier C; Henry-Amar M; Macé-Lesech J; Contesso G
    J Clin Oncol; 1996 Mar; 14(3):869-77. PubMed ID: 8622035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in superficial adult soft tissue sarcomas: analysis of a series of 105 patients.
    Cany L; Stoeckle E; Coindre JM; Kantor G; Bonichon F; Bui BN
    J Surg Oncol; 1999 May; 71(1):4-9. PubMed ID: 10362084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
    Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
    Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of staging systems for localized extremity soft tissue sarcoma.
    Wunder JS; Healey JH; Davis AM; Brennan MF
    Cancer; 2000 Jun; 88(12):2721-30. PubMed ID: 10870054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
    Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
    Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
    Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
    Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.
    Pasquali S; Colombo C; Pizzamiglio S; Verderio P; Callegaro D; Stacchiotti S; Martin Broto J; Lopez-Pousa A; Ferrari S; Poveda A; De Paoli A; Quagliuolo V; Jurado JC; Comandone A; Grignani G; De Sanctis R; Palassini E; Llomboart-Bosch A; Dei Tos AP; Casali PG; Picci P; Gronchi A
    Eur J Cancer; 2018 Apr; 93():28-36. PubMed ID: 29475197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.
    Ferrari A; Brecht IB; Koscielniak E; Casanova M; Scagnellato A; Bisogno G; Alaggio R; Cecchetto G; Catania S; Meazza C; Int-Veen C; Kirsch S; Dantonello T; Carli M; Treuner J
    Pediatr Blood Cancer; 2005 Aug; 45(2):128-34. PubMed ID: 15852434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
    Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
    J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register.
    Trovik CS; Bauer HC; Alvegård TA; Anderson H; Blomqvist C; Berlin O; Gustafson P; Saeter G; Wallöe A
    Eur J Cancer; 2000 Apr; 36(6):710-6. PubMed ID: 10762742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.
    Alvegard TA; Berg NO; Baldetorp B; Fernö M; Killander D; Ranstam J; Rydholm A; Akerman M
    J Clin Oncol; 1990 Mar; 8(3):538-47. PubMed ID: 2407813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult].
    Cany L; Bui NB; Stöckle E; Coindre JM; Kantor G; Ravaud A
    Bull Cancer; 1992; 79(11):1077-85. PubMed ID: 1302534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.